Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor

Transplantation

Volumn 75, Issue 1, 2003, Pages 102-104

  Toro, Carlos ^a   Rodés, Berta ^a   Poveda, Eva ^a   Soriano, Vincent ^a,b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; TAX PROTEIN; VIRUS DNA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DISEASE TRANSMISSION; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN DONOR; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; SPINAL CORD DISEASE; VIRUS LOAD; VIRUS STRAIN; VIRUS VIRULENCE;

ADULT; BASE SEQUENCE; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARAPARESIS, TROPICAL SPASTIC; TISSUE DONORS; VIRAL LOAD;

EID: 0037439658     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200301150-00019     Document Type: Article

References (12)

1. Taylor G, HERN. The epidemiology and clinical impact of HTLV infections in Europe. AIDS Rev 1999; 1: 195-204.
2. Bangham C. The immune response to HTLV-I. Curr Opin Immunol 2000; 12:397-402.
3. Furukawa Y, Yamashita M, Usuku K, et al. Phylogenetic subgroups of HTLV type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000; 182: 1343-1349.
4. Jeffery K, Usuku K, Hall S, et al. HLA alleles determine HTLV-I proviral load and risk of HTLV-I associated myelopathy. Proc Natl Acad Sci U S A 1999; 96: 3848-3853.
5. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383-388.
6. Zarranz JJ, Rouco I, Gómez-Esteban JC, et al. Human T lymphotropic virus type I (HTLV-I) associated myelopathy acquired through a liver transplant. J Neurol Neurosurg Psychiatry 2001; 71: 818.
7. Heneine W, Khabbaz R, Lal R, et al. Sensitive and specific polymerase chain reaction assays for diagnosis of HTLV-I and HTLV-II infections in HTLV-I/II-seropositive individuals. J Clin Microbiol 1992; 30: 1605-1607.
8. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951-1958.
9. Renjifo B, Borrero I, Essex M. Tax mutation is associated with tropical spastic paraparesis/HTLV-I-associated myelopathy but is linked to the cosmopolitan molecular genotype. J Virol 1995; 69: 5925-5927.
10. Ozden S, Seilhean D, Gessain A, et al. Severe demyelinating myelopathy with low HTLV type 1 expression after transfusion in an immunosuppressed patient. Clin Infect Dis 2002; 34: 855-860.
11. Szymocha R, Brisson C, Bernard A, et al. Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J Neurovirol 2000; 6: 350-357.
12. Grant C, Barmak K, Alefantis T, et al. HTLV type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol 2002; 190: 133-159.